<DOC>
	<DOCNO>NCT02334878</DOCNO>
	<brief_summary>This study evaluate effectiveness mesenchymal stem cell treatment stress urinary incontinence due intrinsic sphincter deficiency ; problem weakness damage sphincter muscle responsible continence . Mesenchymal stem cell undifferentiated cell undergo self-renewal &amp; differentiation cell type like muscle cell ; thus use regenerate damage sphincter muscle . In study mesenchymal stem cell obtain bone marrow patient , process , &amp; re-injected periurethrally . Effectiveness compare surgical treatment ( tension-free vaginal tape ) .</brief_summary>
	<brief_title>Stem Cell Therapy Treatment Female Stress Urinary Incontinence</brief_title>
	<detailed_description>** Study setting : The study hold Ain-Shams University Maternity Hospital - urogynecolgy unit ; recruit patient urogynecology outpatient clinic ** Sample size : Fifty female patient stress urinary incontinence due intrinsic sphincter deficiency recruit two group ; group A include 25 patient injected stem cell , &amp; patient refuse surgery primary line treatment , unfit surgery . Group B ; include 25 patient , undergo tension-free vaginal tape operation . The sample size determine accord follow equation : [ P1 ( 100-P1 ) + P2 ( 100-P2 ) ] / ( P2 - P1 ) 2 ; Power test = 80 % Confidence level = 95 % Alpha error = 5 % Assuming success rate preferably use intervention `` tension-free vaginal tape '' patient intrinsic sphincter deficiency P1=80 % ( Schierlitz et al , 2008 ) . Assuming success rate stem cell therapy P2= 90 % ( Smaldone et al , 2009 ) . ** Intervention : 1 . Consent Informed consent take accord World Medical Association ( WMA ) Declaration Helsinki ; Ethical Principles Medical Research Involving Human Subjects . 2 . History Full medical history take patient , together detailed history regard void habit , incontinence , void dysfunction , urinary infection . Questionnaire incontinence , &amp; questionnaire quality life obtain . 3 . Examination Complete physical pelvic examination evaluate presence stress urinary incontinence , &amp; exclude patient mark hypermobility urethra , severe cystocele rectocele . 4 . Urodynamic study A multi-channel urodynamic study use Euet Sensik ® perform include cystometry , urethral pressure measurement , abdominal leak point pressure ( ALPP ) measurement , &amp; residual urine measurement . Patients stress urinary incontinence due intrinsic sphincter deficiency select . Criteria selection : absence involuntary contraction leakage cause stress maneuver ; low ALPP ( &lt; 60 cmH2O ) ; &amp; maximum urethral closure pressure ( MUCP ) &lt; 20-30 cmH2O . Patients void dysfunction exclude ( residual urine volume &gt; 100ml ) . 5 . Cells retrieval , culture , &amp; processing : * Bone marrow aspiration : -Site : posterior superior iliac crest . -Procedure : The patient place lateral decubitus position , top leg flex low leg straight . The iliac crest palpate , preferred sample site mark pen . Aseptic technique employ , include sterile glove gown . The site prepare antiseptic ( povidone-iodine ) , scrub , drape , expose site sample . The skin underlie tissue periosteum infiltrate local anaesthetic ( approximately 10 mL 1 % Xylocaine [ lidocaine ] ) . A 10-mL syringe 25-gauge needle use inject initial 0.5 mL directly skin , raise wheal . A 22-gauge needle use penetrate deeply subcutaneous tissue underlie periosteum , area roughly 1 cm diameter . A skin incision make small surgical blade , bone marrow aspiration needle , stylet lock place , insert . Once needle contact bone , advance slowly rotate clockwise counter clockwise cortical bone penetrate marrow cavity enter . The depth penetration extend beyond initial 1cm . Once within marrow cavity , stylet remove . Using 20 mL syringe , approximately 5 mL bone marrow aspirate . Subsequent specimen obtain attach separate syringe , collect 5 mL time . The sample transfer ethylenediaminetetraacetic acid ( EDTA ) -containing tube . The marrow needle remove , pressure apply aspiration site gauze bleed stop . * Cells processing &amp; culture : - Mononuclear cell ( MNCs ) isolate density gradient centrifugation use Ficol/Hypaque . - Mesenchymal stem cell ( MSCs ) isolate plastic adherence seed MNCs T25 tissue culture flasks complete culture medium ( DMEM , 1 % antibiotics/antifungal , 20 % autologous serum ) . Flasks incubate 37ºC CO2 incubator 3-5 day . - After 5 day , flask evaluate inverted microscope number morphology MSCs . Non-adherent cell discard medium replenish . - Half medium change every 3 day . - Flasks evaluate cell reach 80-90 % confluence . - MSCs harvest use Trypsin-EDTA ( 0.25 % ) 5 minute . Afterwards , trypsin action stop addition autologous serum . - MSCs wash use phosphate buffer saline ( PBS ) , count , test viability use trypan blue exclusion test . - MSC identify use immunophenotypic marker ( positive CD44 negative CD34 ) . - Cells suspend sterile saline , minimum 20 X 106 MSCs cell 10 cc syringe , ready injection . Quality control check sterility performance bacterial aerobic anaerobic culture do ensure complete aseptic condition specimen retrieval , preparation , storage , injection . ( Gunetti et al. , 2012 ) 6 . Injection cell : The patient place lithotomy position . A Foley 's catheter ( size 18 ) insert urethra , local anaesthesia ; retrieve cell ( total 20- 30 million cell per patient 10cc syringe ) ( Sebe et al. , 2011 ) inject submucosal tissue level proximal urethra distal bladder neck ( guide stretch Foley 's catheter ) , 3,9,12 o'clock , inject around 3.5 cc site . 7 . Tension-free vaginal tape ( TVT ) : Another 25 patient undergo surgical intervention , `` tension-free vaginal tape '' operation obstetrics &amp; gynecology department - Ain Shams Maternity Hospital - urogynecology unit . In technique , small midurethral incision make vaginal mucosa , polypropylene 40*1cm mesh tape attach two curved trocars pass lateral urethra &amp; endopelvic fascia retropubic space . The trocar pass along back pubic bone , rectus fascia , two small suprapubic skin incision , tension tape adjust &amp; remain tape cut level skin . 8 . Follow : Follow visit conduct 3months , 6months , 9months , 12months therapy . Clinical examination , incontinence questionnaire , quality life questionnaire , &amp; urodynamic study do . ** Data collection &amp; recording : Each patient case record form ( CRF ) follow data record : - Age , parity - Body mass index ( BMI ) . - Type intervention ( stem cell therapy TVT ) - International Consultation Incontinence Questionnaire-Urinary Incontinence Short Form ( ICIQ-UI SF ) admission &amp; 3m , 6m , 9m , 12m post-injection . - Incontinence Quality Life ( I-QOL ) Instrument Score admission &amp; 3m , 6m , 9m , 12m post-injection . - Cough test admission &amp; 3m , 6m , 9m , 12m post-injection . - Urodynamic study admission &amp; 3m , 6m , 9m , 12m post-injection . - Statistical analysis : Descriptive statistic measure variable express range , mean standard deviation ( metric data ) ; range , median interquartile range ( discrete data ) ; number proportion ( categorical data ) . Pre-injection &amp; post-injection finding compare use t-test Wilcoxon test depend whether measure parameter Gaussian variable . A P-value 0.05 less consider statistically significant . ** Ethical consideration : 1 . Delegation investigator responsibility : The investigator ensure person assist trial adequately inform protocol , &amp; trial-related duty function . The investigator maintain list sub-investigators appropriately qualify person delegate significant trial-related duty . 2 . Patient information inform consent Before admitted clinical study , patient must consent participate nature , scope , possible consequence clinical study explain form understandable . An informed consent document , Arabic language , contain locally required element specifies inform patient . After read informed consent document , patient must give consent writing . The patient 's consent must confirm time consent personally dated signature patient personally dated signature person conduct informed consent discussion . If patient unable read , oral presentation explanation write informed consent form information supply patient must take place presence impartial witness . Consent must confirm time consent orally personally dated signature patient local legally recognize alternative ( e.g. , patient 's thumbprint mark ) . The witness person conduct informed consent discussion must also sign personally date consent document . The original signed consent document retain investigator . The investigator undertake measure specifically require clinical study valid consent obtain . 3 . Confidentiality Only patient number patient initial record CRF , patient name appear document , must keep privacy investigator . The investigator maintain personal patient identification list ( patient number correspond patient name ) enable record identify . 4 . Protocol approval Before begin study accordance local regulation follow , protocol correspond document declare ethical research approval council ob/gyn department , Ain Shams University ; accord WMA Declaration Helsinki .</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<criteria>Symptoms stress urinary incontinence Urodynamic study show stress urinary incontinence due intrinsic sphincter deficiency Pregnant females Hypermobility urethra Mild case ( treatment mainly physiotherapy &amp; pelvic floor exercise ) Urge incontinence / Urodynamic study show detrusor instability Current urinary infection Current severe cystocele rectocele History previous synthetic , biologic fascial suburethral sling surgery external genitalia , bladder neck , bladder urethra Voiding dysfunction ( postvoid residual volume &gt; 100cc )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Stem Cells</keyword>
	<keyword>Mesenchymal</keyword>
</DOC>